At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,821 enrolled
Drug / intervention
Urine sample collection +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low Intervention Study of the Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Against Vaccine Type Pneumococcal Hospitalised Community Acquired Pneumonia (CAP) in Adults 60 Years and Older Using A Test Negative Design Study in A Well-Defined Area of the South of Madrid Region
In Brief
An observational study evaluating Urine sample collection and Saliva collection for Community Acquired Pneumonia (CAP). Completed, enrolled 1,821 participants across 5 sites.
Detailed Summary
Low interventional, prospective, multicentre, hospital-based study involving adults 60 years of age and older hospitalised with CAP at participating sites.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCommunity Acquired Pneumonia (CAP)
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartMar 2021
Primary CompletionOct 2023
Study CompletionMar 2024
TodayJul 2026
First PostedNov 3, 2020
Enrollment StartMar 12, 2021
Primary CompletionOct 25, 2023
Study CompletionMar 24, 2024
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 5.7 years ago
Interventions
Urine sample collectionother
Serotype specific UAD (urinary antigen detection) test
Saliva collectionother
Streptococcus pneumonia identification in saliva samples by culture or PCR / RSV identification in saliva samples by PCR